“…1), the
antidepressant and stop-smoking aid bupropion, antispasmodic agents eperisone and tolperisone, and
the anorectic agent diethylpropion. Cathinones with a wide range of activities have been synthesized
and some may be useful as new therapeutic agents with improved adverse effect profiles for treating
depression, obesity, cocaine and nicotine addiction, and as centrally acting muscle relaxants (Carroll et al, 2009, 2010;
Cozzi et al, 2005; Foley and
Cozzi, 2003; Lukas et al, 2010; Nisijima et al, 1998; Shiozawa et al,
1995). Identified biological targets for cathinones include acetylcholine, serotonin,
dopamine, norepinephrine, histamine, and sigma-1 receptors, voltage-gated sodium and calcium ion
channels, plasma membrane transporters for serotonin, norepinephrine, and dopamine (SERT, NET, and
DAT, respectively) and the vesicle monoamine transporter 2 (VMAT2) (Baumann et al, 2012; Carroll et al, 2009, 2010; Cozzi and Foley, 2003;
Cozzi et al, 1999, 2005, 2007; Foley and
Cozzi, 2003; Fujioka and Kuriyama, 1985; Hofer et al, 2006; Kehr et al,
2011; Kocsis et al, 2005; Slemmer et al, 2000).…”